E-LIB Suche - Ergebnisse für: Dex, Terry

1

Factors associated with therapeutic inertia in individuals ..:

Shabnam, Sharmin ; Gillies, Clare L. ; Davies, Melanie J....
Diabetes Research and Clinical Practice. 203 (2023) - p. 110888 , 2023

Link: https://doi.org/10.1016/..

2

Clinical Benefits of Treating Patients with Type 2 Diabetes..:

Chauhan, Ankita ; Samnaliev, Mihail ; Ken-Opurum, Jennifer...
Diabetes Therapy. 14 (2023) 8 - p. 1331-1344 , 2023

Link: https://doi.org/10.1007/..

3

Effect of delay in treatment intensification in people with..:

Shabnam, Sharmin ; Abner, Sophia ; Gillies, Clare L....
Diabetes, Obesity and Metabolism. 26 (2023) 2 - p. 512-523 , 2023

Link: https://doi.org/10.1111/..

4

iGlarLixi versus premixed insulin initiation in adults with..:

Lajara, Rosemarie ; Heller, Caroline ; Pantalone, Kevin M....
Diabetes, Obesity and Metabolism. 25 (2023) 5 - p. 1249-1260 , 2023

Link: https://doi.org/10.1111/..

5

Advancing Type 2 Diabetes Therapy with iGlarLixi in Older P..:

Munshi, Medha ; Ritzel, Robert ; Hramiak, Irene...
Metabolism. 142 (2023) - p. 155429 , 2023

Link: https://doi.org/10.1016/..

6

Budget Impact Analysis of Intensification with iGlarLixi Co..:

Ken-Opurum, Jennifer ; Srinivas, Sistla S. S. ; Jain, Divya...
Diabetes Therapy. 14 (2023) 12 - p. 2109-2125 , 2023

Link: https://doi.org/10.1007/..

7

Advancing type 2 diabetes therapy with iGlarLixi in older p..:

Munshi, Medha ; Ritzel, Robert ; Jude, Edward B...
Diabetes, Obesity and Metabolism. 26 (2023) 3 - p. 851-859 , 2023

Link: https://doi.org/10.1111/..

8

Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in P..:

Shao, Hui ; Alsaleh, Abdul Jabbar Omar ; Dex, Terry..
Diabetes Therapy. 13 (2022) 9 - p. 1659-1670 , 2022

Link: https://doi.org/10.1007/..

9

Fixed‐ratio combination of insulin glargine plus lixisenati..:

Ferrannini, Ele ; Niemoeller, Elisabeth ; Dex, Terry..
Diabetes, Obesity and Metabolism. 24 (2022) 6 - p. 1159-1165 , 2022

Link: https://doi.org/10.1111/..

10

Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ..:

Yale, Jean-François ; Roborel de Climens, Aude ; Aggarwal, Naresh...
Diabetes Therapy. 14 (2022) 2 - p. 377-386 , 2022

Link: https://doi.org/10.1007/..

11

Glycemic Control Following GLP-1 RA or Basal Insulin Initia..:

Peng, Xuejun Victor ; McCrimmon, Rory J. ; Shepherd, Leah...
Diabetes Therapy. 11 (2020) 11 - p. 2629-2645 , 2020

Link: https://doi.org/10.1007/..

12

Impact of disease duration and β‐cell reserve on the effica..:

Del Prato, Stefano ; Frias, Juan Pablo ; Blonde, Lawrence...
Diabetes, Obesity and Metabolism. 22 (2020) 9 - p. 1567-1576 , 2020

Link: https://doi.org/10.1111/..

13

Efficacy and safety of insulin glargine/lixisenatide (iGlar..:

Handelsman, Yehuda ; Chovanes, Christina ; Dex, Terry...
Journal of Diabetes and its Complications. 33 (2019) 3 - p. 236-242 , 2019

Link: https://doi.org/10.1016/..

14

Clinical Characteristics and Glycemic Outcomes of Patients ..:

Blonde, Lawrence ; Bailey, Timothy S. ; Chao, Jason...
Advances in Therapy. 36 (2019) 9 - p. 2310-2326 , 2019

Link: https://doi.org/10.1007/..

15

When basal insulin is not enough: response to M Davidson:

Umpierrez, Guillermo E. ; Skolnik, Neil ; Dex, Terry...
Diabetes, Obesity and Metabolism. 22 (2019) 4 - p. 711-712 , 2019

Link: https://doi.org/10.1111/..